Objective: Functional capacity is commonly impaired after critical illness. We sought to clarify the relationship between objective measures of physical activity, self-reported measures of healthrelated quality of life, and clinician reported global functioning capacity (frailty) in such patients, as well as the impact of prior chronic disease status on these functional outcomes. Design: Prospective outcome study of critical illness survivors. Setting: Community-based follow-up. Patients: Participants of the Musculoskeletal Ultrasound Study in Critical Care: Longitudinal Evaluation Study (NCT01106300), invasively ventilated for more than 48 hours and on the ICU greater than 7 days. Interventions: None. Measurements and Main Results: Physical activity levels (healthrelated quality of life [36-item short-form health survey] and daily step counts [accelerometry]) were compared to norm-based or healthy control scores, respectively. Controls for frailty (Clinical Frailty Score) were non-morbid, age-and gender-matched to survivors. Ninety-one patients were recruited on ICU admission: 41 were contacted for post-discharge assessment, and data were collected from 30 (14 female; mean age, 55.3 yr [95% CI, 48.3-62.3]; mean post-discharge, 576 d [95% CI, 539-614]). Patients' mean daily step count (5, 803; 95% CI, 4, 813) was lower than that in controls (11, 735; 95% CI, 10, 542; p < 0.001), and lower in those with preexisting chronic disease than without (2, 989 [95% CI,201] vs 7,737 [95% CI, 4,907-10,567]; p = 0.013). Physical activity measures
IntrODuCtIOn
Of the estimated 27 million ICU survivors alive today, over 60% will have experienced sustained and significant impairment of physical function (PF) after hospital discharge (1) . However, the relationship between functional impairment and the presence of chronic disease prior to ICU admission is not well understood.
Such survivor disability has been assessed using objective (2, 3) and subjective (4) tools, with subjective questionnairebased self-reporting (2, 5, 6) being commonly used. Healthrelated quality of life (HRQL) questionnaires have generally been employed as the default for long-term physical, psychological, and cognitive outcomes in survivors of critical illness. Although objective assessment with physical activity (PA) monitoring and compliance analysis (7) may define physical disability in greater detail, the validity of such objective measures, when compared to the subjective measures used in the post-critical care population, is poorly described.
Meanwhile, rehabilitation goals need to be individualized given the increasing variation in medical complexity exhibited by critical illness survivors (8) . Indeed, the lack of benefit demonstrated by some randomized controlled trials of rehabilitation could partly reflect the failure to do so (9) (10) (11) (12) . The current assessment tools used to establish the effectiveness of rehabilitation strategies in ICU survivors may not offer sufficient granularity to detect the variability in functional outcome (2) , requiring large numbers of patients to adequately power interventional clinical trials. Such interventions may be targeted at reducing post-ICU frailty (13, 14) .
We thus aimed to explore the relationship between objective measures of PA, self-reported measures of physical HRQOL, and clinician-reported global functioning (frailty). In addition, we investigated the relationship between chronic disease status prior to critical illness and functional outcome.
MAtErIALS AnD MEtHODS
We studied patients recruited to the Musculoskeletal Ultrasound Study in Critical Care: Longitudinal Evaluation study (NCT01106300, www.clinicaltrials.gov: ethical approval: University College London Ethics Committee A), which assessed the early impact of critical illness on muscle mass (15) . Enrolment and follow-up are shown in Figure S1 (Supplemental Digital Content 1, http://links.lww.com/CCM/B700).
In brief, patients were recruited within 24 hours of admission to a university hospital and a community hospital (August 2009 to April 2011). All were anticipated to 1) be invasively ventilated for greater than or equal to 48 hours, 2) spend greater than or equal to 7 days in the ICU, and 3) survive ICU. Patients were subsequently excluded if these criteria were not met. Patients were also excluded if pregnant, a lower limb amputee, or suffering a primary neuromuscular pathology or active disseminated cancer. At enrolment, written assent was obtained from the next-of-kin, with retrospective patient consent obtained when possible. Chronic disease was defined by hospital and general practice coding for management of chronic disease, plus the Charlson Co-morbidity Index (16) . A home visit 18 months post-ICU discharge was requested from patients, when HRQL and frailty were assessed and an accelerometer fitted. This time point was selected to maximize information about long-term outcomes within the constraints of limited available resources.
Measures of PA
Objective PA was recorded daily using a bi-axial accelerometer armband (SenseWear; BodyMedia, Pittsburgh, PA), and measured over at least 5 days incorporating one weekend and four weekdays. A valid PA assessment was defined as 90% onbody time per day for greater than or equal to 5 days (7) , and data analyzed using SenseWear Professional software (version 6.1). Daily step counts were adjusted for age and time postdischarge, and compared with previously published controls (7) . Patients were blinded to daily step count, such data only being accessible on data download. Daily step variability was taken as the sd of at least 5 days of step data.
Subjective HRQL was assessed using the 36-item shortform health survey (SF-36) Questionnaire v 2.0 (UK version, licensed from QualityMetric, Lincoln, RI) (17) , which were compared to scores from a large published U.K. control cohort (18) . Domain scores and component summary scores were also compared with normbased control scores (mean, 50; sd, 10) provided by inbuilt algorithms (17) . Comparison to population norms is standard for ICU follow-up studies using SF-36 scoring (2, 5, 6) .
Clinical frailty was assessed during ICU survivor home visits using the Clinical Frailty Scale (CFS), a valid tool previously successfully applied in the critically ill (4, 19) . This is a short frailty scale focusing on levels of energy, activity, and exercise; impact of symptoms of medical problems on activities; level of physical and cognitive dependency inside and outside the home; and ability to cope with a minor illness (19) , which correlates with a longer 70-item assessment of frailty (20) . Scores range from one (very fit) to nine (terminally ill) (Table S1, Supplemental Digital Content 1, http://links.lww.com/CCM/B700), and relate to other individuals within the same age range. Study scores were adjusted for time post-ICU discharge. A group of non-morbid controls, age-and gender-matched to the ICU survivors were recruited from the community (n = 30), and their CFS scores assessed from observations on mobility and general lifestyle, using the same technique of passive participant observation and during a similar period (30 min) as for the ICU survivors.
Statistical Analysis
General. Data were assessed for normality using D'Agostino and Pearson omnibus normality tests. Mean values were compared using two-tailed unpaired t tests. Correlations between different measures of PA were determined by Spearman's rank correlation coefficient analysis in order to assess construct validity. A post-hoc power calculation (G*Power 3.1 9.2, Kiel, Germany) was performed to determine whether sample sizes were large enough to show differences between patients with and without chronic disease. Statistical analysis was performed using Statistical Package for Social Sciences, version 22 (SPSS, Armonk, NY). Data are reported as mean (95% CI), except where only mean (sd) control values were available.
Effect Sizes/Sample Size Calculations. Projected PA variables for ICU survivors, and subcohorts with and without chronic disease, were derived from values reported in the literature, enabling effect and sample sizes for these three patient groupings (all survivors, those with chronic disease and those without) to be calculated for future interventional rehabilitation trials using G*Power (3.1 9.2, Kiel, Germany):
1.
Steps: Three levels of daily step count were selected as statistical targets for future rehabilitation studies: A "somewhat active" population mean (8,750 steps/d) for the whole ICU population (21, 22) ; the control level of steps (10,000 steps/d) for ICU survivors without pre-morbid disease (21, 22) ; and a "low-active" mean (6,250 steps/d) for survivors with pre-existing chronic disease (21, 22) ( ; p = 0.014) ( Fig. 1) .
Step variability, assessed by sd, was highly correlated with daily steps (r 2 = 0.67, p < 0.01) ( Fig. 2) demonstrating a potential boundary constraint ( 
Construct Validity Across PF Measures
Construct validity, the degree to which a test measures what it claims to measure, is indicated by the Coefficient of Determination (r 2 ) from regression between experimental and previously validated variables. High correlations across PA measures were maintained when corrected for age and time post-discharge. (abbreviated construct validity is shown in Table 2 ) (full results in Table S5 and Figs. S2 and S3, Supplemental Digital Content 1, http:// links.lww.com/CCM/B700).
PA measures demonstrated good construct validity across all three tools. Bedside physiology variables showed no relationships with these measures ( Table 2) .
Floor and Ceiling Effect
Ceiling and floor effects refer to levels either above or below which variables can no longer be differentiated. No floor or ceiling effects were seen with accelerometer use. In HRQL, a 0% floor was seen across cohorts and domains, though 11.1% of previously healthy patients rated PF at maximal scores. CFS scoring demonstrated a floor effect of 0.07%, i.e., one patient in each sub-cohort was either very severely frail or terminally ill; and a ceiling effect of 0.04%, i.e., one patient was very active for the age group.
Statistical Calculations for Future trial Design
Estimated effect and sample sizes varied considerably ( Table 3) , likely secondary to the boundary constraint effect seen in patients with lower step counts (those with pre-morbid chronic disease).
DISCuSSIOn
In our study, three independent methods of assessmentpatient-reported HRQL, clinician-reported frailty score, and objective accelerometry-demonstrate impaired PA in ICU survivors, in agreement with published data (2, (24) (25) (26) (27) (28) (29) . However, we have shown that this impairment is not uniform, being greatest in those with pre-morbid chronic disease.
Our data show that accelerometry-derived data (daily step count) correlate well with other measures of physical incapacity (physical aspects of HRQL and frailty score) and demonstrate no floor or ceiling effects, unlike the SF-36 and CFS scores, confirming the validity of its use ( B700 ). In addition, new insights are apparent from considering variation in daily PA. Thus, variation in daily step count was greatest in those most active, consistent with a boundary constraint effect: those with high exercise capacity can choose activity up to their maximal limit, while those least able to exercise are constrained to a narrow range of activity levels. The use of activity monitors-which are well tolerated and show good compliance in this patient group-may therefore add greater granularity to assessment of functional disability post-critical illness (Fig. 1) .
Frailty is associated with greater risk of institutionalization, lower survival, and significantly lower HRQL in ICU survivors 12 months post-ICU admission (4, 29) . We identified frailty Critical Care Medicine www.ccmjournal.org e367 in 37% of ICU survivors, compared with the 32% prevalence on ICU admission recently reported (4) . Our data suggest that frailty correlates strongly with PF SF-36 scores and lower daily step counts, and may be a useful alternative outcome measure, especially given the potential of translating multimodal community interventions from the ageing literature (30, 31) .
Implications for Prospective Interventional trials
ICU survivors with and without chronic disease appear to behave as separate cohorts: by 18 months, the latter have daily step counts only one-third lower than those of healthy controls, with substantially greater HRQL and significantly less frailty than the cohort with pre-morbid disease, reflecting a trajectory of recovery. In conjunction with a recent secondary analysis of a previously published exercise intervention study (32) , this finding strengthens the argument that successful long-term interventions in ICU survivors will require stratification based on the presence of pre-morbidity, i.e., a personalized rehabilitation approach.
All three tools show good construct validity across assessments with little evidence of floor/ceiling effects suggesting that the assessment method should be determined by the purpose of the intervention-e.g., daily step count for an exercise only-intervention, and HRQL or frailty scales for multimodal interventions. Importantly, combined use of these outcome measures may elucidate useful components of multimodal interventions, especially in the setting of negative or neutral trial results (9) (10) (11) (12) .
The effect size calculations reveal potential difficulties in trial design, e.g., achieving the effect size necessary for CFS use would likely require a major interdisciplinary intervention (14) . When considering physical rehabilitation, stratification of cohorts by presence or absence of chronic disease can reduce numbers significantly. However, if a mixed cohort is used, the presence of high numbers of pre-morbidly healthy patients may result in a high proportion of "false negative" results. This potential skew is likely a result of the boundary constraint demonstrated in this study: significant variation in step count in survivors without pre-morbid disease necessitates larger sample sizes. The shaded areas in Figure 4 provide a hypothetical representation of the potential for rehabilitation in these two cohorts of ICU survivors: it shows the "rehabilitation gap" between their observed PA levels 18 months post-ICU admission, and what might be achieved with suitable intervention.
Post-ICU HRQL differs with the presence or absence of preadmission chronic disease. The nature of rehabilitation efforts required, and the maximal gain which they might deliver, is thus likely to vary between such groups; ICU-acquired PA deficits may also contribute to heterogeneity in response to rehabilitation. This is not clear when only the average impact is considered. The differences in scores between survivors without pre-morbidity and the whole ICU survivor group suggest that scores from previously healthy survivors could introduce type II errors, potentially contributing to the lack of positive reports from intervention trials (9) (10) (11) (12) . In addition, psychosocial deficits (including depression and posttraumatic stress disorder), which are known to negatively impact PA capabilities, have been reported in ICU survivors (33) and may contribute to their physical dysfunction.
Limitations
Primary prevention of muscle wasting (34) and proactive rehabilitation (35) mandate enrolling patients at ICU admission for trials (9) . However, high dropout rates are well described in the literature, primarily due to mortality, either in hospital or during the first few months in the community (9, 12, (36) (37) (38) (39) . From our data, an 18-month follow-up study on 100 survivors would require recruiting 303 patients on admission to ICU. The use of inner city tertiary care locations as study sites increases the risk of patients being lost to follow-up due to the widespread locations of patients, and the lack of a fixed address for a proportion of the target population. In this pilot study, there were insufficient resources for follow-up beyond 100 miles, and this contributed to the numbers lost. Age-adjustment of results overcame any potential influence from mean age differences in those followed up versus not followed up. Approaches to enable all measurements from each participant to be used, regardless of time of drop-out (40) , may be worth investigating for future studies.
The small sample size, preventing stratification by diagnostic category (15) and extrapolation to specific patient subgroups, may impact generalizability. That said, ICU-induced muscle loss and subsequent physical debility appear to relate to the state of critical illness per se, rather than being linked to a specific diagnosis (15) . Twenty-seven survivors contributed full data, a similar sample size to other studies of PA in ICU survivors and individuals with chronic disease (7, 28, 41) . Rates of attrition secondary to mortality and loss to follow-up were comparable to a high-quality published 1-year outcome study (28) , highlighting the difficulty of research in this population. Further, a post-hoc power calculation (Table S6 , Supplemental Digital Content 1, http://links.lww.com/CCM/B700) suggests that sufficient numbers of participants were studied to detect a betweengroups difference using PA monitoring or the PCS of the SF-36 questionnaire. This is a further demonstration of the potentially powerful effect of stratification of outcome studies (32) .
Accelerometers may overestimate step count compared with pedometer-based values (42), though the strong correlations observed between objective and subjective measures suggest that this is of minimal impact.
COnCLuSIOnS
Activity monitoring appears well tolerated by ICU survivors, with a high level of compliance. Both subjective and objective measures suggest that PA levels are reduced 18 months post-discharge in ICU survivors, being worst in those with pre-admission chronic disease states. This suggests that rehabilitation strategies and targets may need to differ for individuals with or without pre-morbid disease.
